-transparent.png){kind=logo}
We evaluated the effect of flunarizine (Fz) (10 mg/d) on migraine in a double-blind placebo-controlled design. The attacks' frequency, duration, severity and associated symptoms were compared before and after treatment. Forty-two patients completed a three-month trial period; 21 patients received Fz and 21 placebo. Statistical analysis showed no significant difference between Fz and placebo (p > 0.05). In this study Fz was not more efficient than placebo in migraine.
Related Publications
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
November 1981,
Headache,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
March 1988,
Cephalalgia : an international journal of headache,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
May 1985,
Cephalalgia : an international journal of headache,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
March 1986,
Cephalalgia : an international journal of headache,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
January 1988,
Cephalalgia : an international journal of headache,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
January 2001,
Headache,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
November 1983,
JAMA,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
December 1980,
Angiology,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
January 1984,
Clinical neurology and neurosurgery,
S M al Deeb, and
N Biary, and
Y Bahou, and
M al Jaberi, and
W Khoja
February 2008,
Neurology,
